Laboratory panels also broadened to incorporate inflammatory biomarkers (e.g., CRP, γ-GT) and cyst fluid tumor antigens (e.g., CEA), demonstrating an awareness of the interplay between inflammatory, hemorrhagic, and neoplastic processes. This evidence concerns the gene CRP and neoplasm.